Price Alert

Royalty Pharma (RPRX)

NASDAQ: RPRX · Real-Time Price · USD

36.34

-0.16 (-0.44%)

At close: Aug 15, 2025, 3:59 PM

36.08

-0.72%

After-hours: Aug 15, 2025, 07:21 PM EDT

Royalty Pharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	2.31B	2.26B	2.26B	2.27B	2.24B	2.24B	2.35B	2.32B	2.36B	2.36B	2.24B	2.25B	2.26B	2.28B	2.29B	2.28B	2.24B	2.19B
Cost of Revenue	1.65M	7.65M	591.25M	667.77M	943.25M	1.18B	713.68M	642.84M	670.76M	535.25M	422.12M	682.95M	383.69M	283.7M	283.7M	146.54M	146.54M	146.54M
Gross Profit	1.73B	2.26B	1.67B	1.6B	1.29B	1.06B	1.64B	1.68B	1.69B	1.82B	1.82B	1.56B	1.88B	1.99B	2.01B	2.14B	2.09B	2.05B
Operating Income	1.84B	1.9B	1.29B	1.54B	960.3M	939.51M	1.49B	974.59M	1.02B	994.16M	734.91M	792.99M	903.83M	1.42B	1.43B	1.59B	1.8B	1.46B
Interest Income	46.16M	51.22M	47.34M	44.81M	50.73M	63.01M	72.29M	109.64M	100.24M	85.51M	78.33M	45.12M	43.35M	46.47M	53.53M	64.11M	53.43M	42.12M
Pretax Income	1.66B	1.77B	1.33B	1.71B	1.03B	1.19B	1.7B	372.47M	470.81M	611.07M	230.06M	893.76M	895.15M	1.21B	1.24B	1.55B	1.96B	1.75B
Net Income	1.02B	1.09B	858.77M	1.15B	673.24M	798.86M	1.13B	30.32M	176.04M	252.92M	-127.71M	490.37M	374.46M	510.74M	619.73M	782.82M	971.89M	973.19M
Selling & General & Admin	507.73M	290.13M	237.08M	228.08M	228.59M	221.52M	249.56M	263.79M	257.25M	261.46M	227.3M	200.24M	198.13M	191.21M	182.83M	186.66M	189.08M	186.96M
Research & Development	352.5M	52.5M	2.5M	2.5M	52.5M	52.5M	52.5M	102M	77M	77.11M	177.11M	230.43M	295.43M	297.94M	200.08M	104.26M	18.76M	21.42M
Other Expenses	-395.68M	-404.17M	-860.63M	-946.63M	-720.74M	-507.22M	195.19M	427.04M	733.8M	838.43M	909.91M	596.25M	290.39M	184.57M	-5.68M	79.14M	210.94M	211.3M
Operating Expenses	464.55M	363.32M	971M	722M	1.28B	1.3B	862.23M	1.31B	1.31B	1.18B	1.31B	1.3B	1.21B	857.35M	858.75M	694.47M	439.74M	731.32M
Interest Expense	266.2M	246.54M	225.51M	206.75M	186.28M	184.21M	186.93M	186.89M	187.83M	187.85M	187.96M	187.98M	185.33M	175.79M	166.14M	157.17M	144.28M	141.05M
Selling & Marketing Expenses	n/a	n/a	n/a	-185K	-185K	-185K	-185K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	464.55M	363.32M	971M	722M	1.28B	1.3B	862.23M	1.31B	1.31B	1.18B	1.31B	1.3B	1.21B	857.35M	858.75M	694.47M	439.74M	731.32M
Income Tax Expense	186.46M	126M	126M	223M	223M	223M	223M	139K	2.72M	189.81M	357.77M	357.63M	355.05M	167.96M	n/a	-531.38M	-197.76M	-197.76M
Shares Outstanding (Basic)	423.51M	433.44M	447.63M	447.63M	451.02M	448.62M	446.57M	448.44M	450.4M	445.61M	443.17M	607.23M	607.21M	607.2M	428.23M	428.23M	409.34M	389.76M
Shares Outstanding (Diluted)	562.3M	578.1M	592.73M	592.73M	596.91M	597.48M	446.57M	601.14M	605.86M	607.25M	443.17M	607.23M	607.21M	607.2M	607.17M	607.17M	607.16M	607.15M
EPS (Basic)	2.69	2.85	2.31	2.96	1.51	1.79	2.54	0.05	0.25	0.24	-0.59	0.81	0.69	1.27	1.52	1.94	2.49	2.66
EPS (Diluted)	2.04	2.20	1.80	2.56	1.51	1.78	2.53	0.04	0.24	0.24	-0.59	0.81	0.69	1.27	1.44	1.87	2.42	2.59
EBITDA	1.89B	2.29B	1.83B	2.15B	1.44B	1.28B	1.8B	516.39M	615.67M	755.95M	425.3M	1.11B	1.16B	1.37B	1.38B	1.69B	1.9B	1.56B
EBIT	1.93B	2.01B	1.56B	1.92B	1.22B	1.37B	1.89B	559.43M	583.53M	563.04M	226.72M	889.72M	1B	1.37B	1.38B	1.68B	1.89B	1.55B
Depreciation & Amortization	n/a	560M	1.29B	1.29B	1.29B	734.03M	5.67M	77.92M	76.48M	235.84M	240.09M	172.43M	178.24M	23.2M	23.2M	23.2M	23.4M	23.4M